M Second Phase of CDMO Investment Builds on 2025 $6M Expansion, Funding Facility Upgrades and Increased Capacity for Suppository, Semi-Solid, and Oral Solid Dose Capacity —— Enhancements Strengthen ...
DynoChem Platform Designed to Facilitate API Process Development and Scale-up Already used by 11 of the world’s biggest pharmaceutical companies, the DynoChem (www.scale-up.com) platform was developed ...
New color identification process dramatically improves selection consistency. Greenville, NC, March 23, 2011 --(PR.com)-- If you're a scientist working with an active pharmaceutical ingredient (API) ...
In this interview, NewsMed talks to Dr. James Mencel's Guidance about Scaling Up API Processes. Could you introduce yourself and your experience in the pharmaceutical industry? I obtained a B.S. in ...
The patent covers intermediate compounds and processes for the preparation of Fingolimod NESS ZIONA, Israel, Feb 18, 2014 (BUSINESS WIRE) -- Mapi Pharma Ltd. ("Mapi" or the "Company"), a developer of ...
HRV Global Life Sciences (HRV Pharma), India’s first integrated Virtual API and Pharmtech company, entered into a comprehensive, multi-year contract development & manufacturing (CDMO) partnership with ...
The track by which API manufacturing processes are prepared for commercial use is comparable to overlapping integrative process evaluations at commercial scale. This ensures the process is ...
LONGMONT, Colo.--(BUSINESS WIRE)--Avista Pharma Solutions, Inc. (“Avista Pharma”) has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, ...
HRV Global Life Sciences (HRV Pharma), India’s first integrated Virtual API and Pharmtech company, announced a unique, comprehensive, multi-year contract development & manufacturing (CDMO) partnership ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results